Natalie Sacks, Chief Medical Officer at Harpoon Therapeutics, Inc. (HARP), sold 1,522 shares at $14.77 ($22K) on 2020-05-18, disclosed to the SEC on 2020-05-20.
Scheduled sale ($22k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HARP | SELL | 2020-04-15 | $110K | — | Filing → |
| HARP | SELL | 2020-04-08 | $15K | — | Filing → |
| HARP | SELL | 2020-03-18 | $18K | — | Filing → |